Levitee Labs (CSE:LVT) Inc said it generated a combined $1,553,728 in unaudited revenue during September 2021 and October 2021.
The company said it has seen consistent growth across all its divisions, with accumulated revenue from September to October broken down into the following subdivisions -- 28.1% for Levitee Clinics, 40.7% for Levitee Pharmacies, and 31.1% for Earth Circle Organics and other wellness products.
Earth Circle Organics, Levitee’s direct-to-consumer and wholesaler of supplements and superfoods products, increased sales 7.7% from September to October.
READ: Levitee Labs announces acquisition of addiction clinics, pharmacies for expanding its pain and addiction relief services
Levitee said the sales growth stems from further scaling its direct-to-consumer business and optimization of the multidisciplinary aspects of its healthcare assets, incorporating novel mental health and treatment modalities.
“Creating a meaningful impact on our communities and building shareholder value are not mutually exclusive,” said Levitee Labs (CSE:LVT) CEO Pouya Farmand in a statement.
“We are proud that Levitee Labs (CSE:LVT) is now the largest non-governmental provider of addiction care in the Province of Alberta, servicing over 35,000 patients annually while building shareholder value for our investors through centralizing accretive acquisitions, technologically enhancing our portfolio of assets, and integrating new treatment modalities for our patients.”
Farmand added: “As we march forward with the overall advancement of the Levitee Labs portfolio of wellness assets, we are proud to be generating substantive and consistent recurring revenue and we look to aggressively expand on this positive momentum in the ensuing months.”
The company said it will look to maintain its consistent growth trajectory and execute on its aggressive expansion plans for the upcoming 12 months. The goal remains to generate revenue through strategic M&A, increasing margins, and further developing its asset portfolio through organic growth.
Contact the author: patrick@proactiveinvestors.com
Follow him on Twitter @PatrickMGraham